This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Immunoglobulin (IgG) Replacement Therapy Market

Immunoglobulin (IgG) Replacement Therapy Market:Global Industry Analysis 2015 - 2019 and Opportunity Assessment; 2020 - 2030

Market Insights on Immunoglobulin (IgG) Replacement Therapy covering sales outlook, demand forecast & up-to-date key trends

Immunoglobulin (IgG) Replacement Therapy Market Overview

Immunoglobulin is a type of antibody present in blood plasma. Immunoglobulin (IgG) replacement therapy is a treatment given to boost your antibody level when they are low. Immunoglobulin (IgG) replacement therapy involves infusion of antibody into the body via intravenous or subcutaneous route that strengthens the immune system to fight against several infections.

Immunoglobulin (IgG) replacement therapy is used in the treatment of immunodeficiency disease.Demand for Immunoglobulin (IgG) replacement therapy is increasing as it is the only effective and available therapy option in the market. Immunoglobulin (IgG) replacement therapy market is expected to grow rapidly during the forecast period.

During this COVID-19 pandemic, pharmaceutical companies, medical devices companies and also biotechnology companies are facing rapid challenges that are arising from the disruption in supply chains and the need to change business processes.

Flow of patients into the hospitals and clinics have been reduced as a result number of immunoglobulin (IgG) replacement therapy performed is reduced.  There is a lack of supply of various products and equipment required for therapy which is hampering the Immunoglobulin (IgG) replacement therapy market.

Immunoglobulin (IgG) Replacement Therapy Market: Drivers and Restraints

Increasing prevalence of immunodeficiency diseases is a major factor driving the immunoglobulin (IgG) replacement therapy market. It has been reported that approximately 6 million people are suffering from primary immunodeficiency diseases.

Ageing weakens the immune that leads to higher susceptibility of patients towards acquiring an infectious disease. Hence, increasing geriatric population is expected to boost the Immunoglobulin (IgG) replacement therapy market.

The rising prevalence of lifestyle-associated problems such as antibody deficiency disorder and obesity is also expected to drive growth. Other factors contributing to the growth of the Immunoglobulin (IgG) replacement therapy market are growing healthcare expenditure in many regions and emerging economies.

Customize this Report

Let us know your requirement to get
100% FREE customization

Immunoglobulin (IgG) Replacement Therapy Market: Overview

Based on the route of administration, the intravenous route is most commonly used in the Immunoglobulin (IgG) replacement therapy market. The subcutaneous route of administration is expanding due to fewer side effects and shorter response time.

Based on the application, hypogammaglobulin is dominating the segment in the Immunoglobulin (IgG) replacement therapy market due to its increasing prevalence across the globe. It is the most common type of primary immunodeficiencies which accounts for 50% of cases.

Immunoglobulin (IgG) replacement therapy market is experiencing a rapid boost owing to a growing number of FDA approval. Many companies are entering the market with its innovative products and advanced technology.

Market leaders are focusing on extensive R&D for the development of cost-effective immunoglobulin replacement therapy with lesser side effects. Key players are adopting various strategies such as collaborative agreements, distribution mergers and acquisitions to gain a greater share by increasing market penetration.

Immunoglobulin (IgG) Replacement Therapy Market: Region-wise Outlook

North America and Europe are expected to dominate the global immunoglobulin (IgG) replacement therapy market due to the increasing awareness of products involved in the treatment of immunodeficiency diseases, developing focus of clinicians towards these therapies.

Increasing healthcare expenditure and awareness in the developing region like Asia-Pacific is expected to drive the global immunoglobulin (IgG) replacement therapy market growth over the forecast period. Rising population in the countries like India and China is further likely to drive the growth of the Immunoglobulin (IgG) replacement therapy market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Immunoglobulin (IgG) Replacement Therapy Market: Key Market Participants

Some of the market participants in the global immunoglobulin (IgG) replacement therapy market identified across the value chain include:

  • Octapharma AG
  • Baxter International Inc.
  • Grifols
  • S.A.
  • LFB Group 
  • CSL Limited
  • Kedrion Biopharma
  • BDI Pharma Inc.
  • Kamada Ltd.
  • China Biologics Products, Inc.
  • Abeona Therapeutics

The report covers exhaust analysis on

  • Immunoglobulin (IgG) Replacement Therapy Market Segments
  • Immunoglobulin (IgG) Replacement Therapy  Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (India, ASEAN, Australia & New Zealand)
  • China
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Immunoglobulin (IgG) Replacement Therapy Market: Segmentation

By Route of Administration:

  • Intravenous
  • Subcutaneous

By Application:

  • Hypogammaglobulinemia
  • Immunodeficiency Diseases
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Congenital AIDS
  • Chronic Lymphocytic Leukemia
  • Myasthania Gravis
  • Multifocal Motor Neuropathy
  • Kawasaki Disease
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Immunoglobulin (IgG) Replacement Therapy Market